These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 19569193

  • 1. Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody.
    Miao F, Velayudhan A, DiBella E, Shervin J, Felo M, Teeters M, Alred P.
    Biotechnol Prog; 2009; 25(4):964-72. PubMed ID: 19569193
    [Abstract] [Full Text] [Related]

  • 2. Predicting diafiltration solution compositions for final ultrafiltration/diafiltration steps of monoclonal antibodies.
    Teeters M, Bezila D, Benner T, Alfonso P, Alred P.
    Biotechnol Bioeng; 2011 Jun; 108(6):1338-46. PubMed ID: 21328314
    [Abstract] [Full Text] [Related]

  • 3. Mechanistic model of pH and excipient concentration during ultrafiltration and diafiltration processes of therapeutic antibodies.
    Ladwig JE, Zhu X, Rolandi P, Hart R, Robinson J, Rydholm A.
    Biotechnol Prog; 2020 Sep; 36(5):e2993. PubMed ID: 32185869
    [Abstract] [Full Text] [Related]

  • 4. A Small-Scale Process for Predicting Donnan and Volume Exclusion Effects During Ultrafiltration/Diafiltration Process Development.
    Abel J, Kosky A, Ball N, Bacon H, Kaushik R, Kleemann GR.
    J Pharm Sci; 2018 May; 107(5):1296-1303. PubMed ID: 29339134
    [Abstract] [Full Text] [Related]

  • 5. Effect of protein and solution properties on the Donnan effect during the ultrafiltration of proteins.
    Bolton GR, Boesch AW, Basha J, Lacasse DP, Kelley BD, Acharya H.
    Biotechnol Prog; 2011 May; 27(1):140-52. PubMed ID: 21312362
    [Abstract] [Full Text] [Related]

  • 6. Designing scalable ultrafiltration/diafiltration process of monoclonal antibodies via mathematical modeling by coupling mass balances and Poisson-Boltzmann equation.
    Ambrožič R, Arzenšek D, Podgornik A.
    Biotechnol Bioeng; 2021 Feb; 118(2):633-646. PubMed ID: 33049074
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Predicting Formulation Conditions During Ultrafiltration and Dilution to Drug Substance Using a Donnan Model with Homology-Model Based Protein Charge.
    Kannan A, Chinn M, Izadi S, Maier A, Dvornicky J, Fedesco M, Day E, Ladiwala A, Woys A.
    J Pharm Sci; 2023 Mar; 112(3):820-829. PubMed ID: 36336103
    [Abstract] [Full Text] [Related]

  • 13. An alternate diafiltration strategy to mitigate protein precipitation for low solubility proteins.
    Gefroh E, Lutz H.
    Biotechnol Prog; 2014 Mar; 30(3):646-55. PubMed ID: 24449613
    [Abstract] [Full Text] [Related]

  • 14. Small molecule clearance in ultrafiltration/diafiltration in relation to protein interactions:Study of citrate binding to a Fab.
    Harinarayan C, Skidmore K, Kao Y, Zydney AL, van Reis R.
    Biotechnol Bioeng; 2009 Apr 15; 102(6):1718-22. PubMed ID: 19132743
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Explainable Machine Learning Models to Predict Gibbs-Donnan Effect During Ultrafiltration and Diafiltration of High-Concentration Monoclonal Antibody Formulations.
    Chen CS, Ujiie S, Tanibata R, Kawase T, Kobayashi S.
    Biotechnol J; 2024 Oct 15; 19(10):e202400212. PubMed ID: 39385541
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. pH variations during diafiltration due to buffer nonidealities.
    Baek Y, Yang D, Singh N, Arunkumar A, Ghose S, Li ZJ, Zydney AL.
    Biotechnol Prog; 2017 Nov 15; 33(6):1555-1560. PubMed ID: 28840650
    [Abstract] [Full Text] [Related]

  • 20. Continuous background correction of refractive index signal to improve monoclonal antibody concentration monitoring during UF/DF and SPTFF operations.
    Webster TA, Turner K, DuBois C, MacDougall R, Mason C.
    Bioprocess Biosyst Eng; 2022 Apr 15; 45(4):647-657. PubMed ID: 34989873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.